BRIC Diagnostic Imaging Equipment Market 2025 – 2034

Reports Description

As per the BRIC Diagnostic Imaging Equipment Market conducted by the CMI Team, the BRIC Diagnostic Imaging Equipment Market is expected to record a CAGR of 9.15% from 2025 to 2034. In 2025, the market size is projected to reach a valuation of USD 9.28 Billion. By 2034, the valuation is anticipated to reach USD 20.61 Billion.

Overview

The BRIC diagnostic imaging equipment market is attracting considerable attention, as it represents a crucial part of modern healthcare, fueled by increasing demand for advanced, accurate, and patient-centric approaches to diagnostics. Increasing focus on early detection of disease, as well as non-invasive imaging and data-driven healthcare, has placed this market at the forefront of medical development and innovation. Leading manufacturers are diversifying their product offerings with AI-enabled imaging technologies, portable diagnostic devices, and affordable digital imaging platforms to meet the changing requirements of hospitals and diagnostic centers.

The leading regions are North America and Europe, which historically have strong healthcare systems, a favorable regulatory process for diagnostic technology, and high adoption of advanced imaging technologies. The Asia-Pacific region is experiencing the fastest growth, with the digitalization of healthcare, increasing medical infrastructure, and funding initiatives for new diagnostic innovation.

Key Trends & Drivers                                                                                                  

The BRIC Diagnostic Imaging Equipment Market Trends present significant growth opportunities due to several factors:

• Increasing in Disease Burden: The incidence of disease in the BRIC countries is rising rapidly, especially due to non-communicable diseases (NCDs), cancers, and diseases of aging, which causes increasing demand for diagnostic imaging modalities. For instance, from 2000-2016 in Brazil, China, India, and South Africa, annual NCD deaths increased by 13.6 thousand, 154 thousand, 108 thousand, and 5.1 thousand, respectively, whereas Russia experienced small declines. In BRICS, multiple myeloma incidence and mortality have nearly quadrupled from 1992-2021, while age standardized incidence rates (ASIR) and mortality (ASMR) nearly doubled. The incidence of neurological disease in China rose from about 7541.9 per 100,000 in 1990 to about 8031.4 per 100,000 in 2021; Brazil had modest increases too, while India’s rate remained relatively stable with some recent increases. Additionally, early-onset gastric cancer remains an issue across the expanded BRICS group, and notably, China and Russia currently have some of the highest age‐standardized death rates. Since diagnostic imaging is paramount in the early detection, staging, and management of many of the increasing diseases (e.g., cancer, neurological diseases, etc.), the correlative increase in disease is a key driver of the BRIC diagnostic imaging market, and parts of valuation and market uptake should consider how hospitals and clinics will require, need more access to, or simply want better and better accessible diagnostic imaging.

• Increasing Investments, Funds, And Grants for The Modernization of Imaging Facilities: Enhanced investments, private equity funds, and targeted modernization grants for imaging facilities are redefining the BRIC diagnostic imaging market. The infusion of public-sector capital (national health programs, regional modernization funds, and infrastructure grants) allows hospitals and diagnostic centers to replace outdated analog imaging systems with digital radiography, advanced CT and MRI scanners, and PACS. At the same time, increasing private equity into imaging startups and venture capital to REPs (radiology equipment providers) and vendor financing opportunities are lowering barriers to acquisition and spurring purchases of next-generation modalities and AI-enabled image-analysis packages. These flows of capital are increasing capacity in tier-2 and tier-3 cities, reducing procurement cycles, and increasing average ticket size per transaction, as facilities opt for higher-spec machines. The result is increased demand not only for new machines but also for the installation, maintenance contracts, training solutions, and software subscriptions — which provide a recurring revenue stream for OEMs and service providers. Overall, targeted funding for modernization will alter the market dynamics from replacement-driven sales to technology-driven upgrades and service-based partnerships in BRIC markets.

Significant Threats

The BRIC Diagnostic Imaging Equipment Market has several major threats that may hinder growth and profitability now and in the future, including:

• High Equipment and Maintenance Costs: The significant cost of purchasing and sustaining high-end diagnostic imaging systems represents a notable risk in the BRIC markets. The up-front investment in MRIs and CT scanners is high, compounded by import duties and logistics costs, which drive up final prices and price out smaller hospitals and diagnostic centres. For instance, a high-end MRI system typically costs USD 1 million to USD 3 million without service contracts or periodic software upgrades. Additionally, the absence of local component manufacturing in some countries (Brazil and Russia) increases imports and repair times. There are regular expenses related to maintenance, calibration, and part replacement to cover throughout the machine’s life cycle. Many public health facilities do not have budgets (or large budgets) early on to make purchases since equipment is typically not acquired during the budget approval cycle. All these factors contribute to equipment limitations in rural and semi-urban areas, thereby reducing market penetration despite a rise in diagnostic demand.

Opportunities

• Rising Healthcare Investments and Infrastructure Expansion: The increasing investments in healthcare – both public and private – across BRIC countries are helping to boost the uptake of diagnostic imaging systems significantly. Many national governments are focused on achieving modernization in their hospitals and diagnostic centres to bring their medical infrastructure up to date and enable advanced care to be accessed by consumers. For instance, India’s increase of more than 13% in 2024 healthcare budget allocation – a large portion of which is earmarked to upgrading public hospitals and radiology departments engaged in the Ayushman Bharat Digital Mission – demonstrates this focus. In China, the “Healthy China 2030” plan and 14th Five-Year Plan are about digitizing healthcare through the purchasing of high-end CT, MRI, and ultrasound systems in tertiary and regional hospitals. Similarly, healthcare modernization programs in Brazil and the National Project “Healthcare” in Russia are focused on utilizing funds for upgrading their imaging scopes via existing teleradiology networks and through the addition of AI guided imaging. Continued investment will drive even greater capital to increase the installed base of diagnostic imaging systems. Those developments will allow both global and local manufacturers to deliver imaging systems that are technologically advanced, energy-efficient, and integrated with AI systems – which create even more opportunities for diagnostic imaging.

Category Wise Insights

By Modality

• Organic X-Ray Systems: Due to their low cost and widespread applications in traumatic, dental, and chest imaging, X-ray systems represent a significant portion of the BRIC diagnostic imaging equipment market. Furthermore, the transition to digital radiography and portable X-ray systems is improving workflow efficiency and contributing to early detection of diseases in both urban and rural healthcare settings in India and China.

• Nuclear Imaging Systems: The use of nuclear imaging systems, including PET and SPECT scanners, is increasing among BRIC countries due to the rising prevalence of cancer and developments in molecular imaging technology. Research development for investment in oncology, along with the establishment of hybrid PET/CT facilities, is expanding access to precision diagnostics in the regions, especially in tertiary care hospitals in China and Brazil.

• MRI Systems: A significant percentage of growth demand is being generated for MRI systems, as there is the rising prevalence of neurological, musculoskeletal, and cardiovascular diseases. MRI access and affordability efforts are being pursued with technology advances like low-helium magnets, AI-based image reconstruction, and rapid acquisition scanning protocols. India and China are emerging markets, as indigenous MRI systems are now being created by local manufacturers as a result of national healthcare and initiative projects.

• Mammography Systems: With breast cancer screening programs growing across BRIC countries, the use of mammography systems is starting to grow. Government awareness campaigns and public-private collaborations are helping screening coverage in urban and semi-urban areas. New technology like digital breast tomosynthesis and AI-based imaging interpretation is now being adopted at diagnostic centers and women’s health clinics.

• Ultrasound Imaging Systems: In BRIC countries, ultrasound systems are widely used in the diagnostic imaging market, attributed to their low costs, portability, and non-invasive use. The installation of ultrasound transformers has driven ultrasound-based imaging into new adoption markets, including expanding maternal health programs and point-of-care applications in urban, rural, and remote areas. Portable ultrasound systems and handheld ultrasound devices are becoming more popular for quick diagnostics and community screening initiatives.

• CT Scanners: Technological developments like new low-dose radiation options, improved speed in scans, and development in the interpretation of images through AI-based analysis continue to improve accuracy in diagnosis. Ongoing investments in the modernization of hospitals across China, India, and Brazil continue to drive the adoption of CT scanners.

By End-User

• Hospitals : Hospitals still account for the most significant end-users of diagnostic imaging equipment in BRIC countries, aided by government funding and tertiary care center modernization. The emergence of hospital networks, enhanced reimbursement models, and the integration of imaging with electronic health records are all propelling upgrades and installations of imaging equipment in both public and private hospital chains.

• Diagnostic Imaging Centers: Diagnostic imaging centers are growing rapidly as patients increasingly prefer standalone specialized and affordable imaging services. Standalone diagnostic chains and AI-driven teleradiology platforms are growing rapidly and extending imaging services across borders and major metropolitan cities. The importance of imaging centers fills in healthcare gaps in semi-urban and rural settings.

Historical Context

The BRIC diagnostic imaging equipment sector emerged from small and regionally driven companies that supported local hospitals, clinics, and diagnostic centers with basic imaging equipment with limited functionality and capability of export. Early manufacturers presented their newly developed technologies and conventional imaging equipment, making minimal use in any export market. As the demand for accessible, accurate, and efficient diagnostic healthcare increased, the BRIC diagnostic imaging market began, like the rest of the world, to evolve with innovations in imaging modalities, integration of artificial intelligence (AI) into diagnostic imaging, and investment by the healthcare system in digital healthcare infrastructure.

The sector became an evolving base for investment in innovation, automation, and data-driven imaging solutions. The current state of the BRIC diagnostic imaging equipment market has changed from a specialized segment of regionally focused enterprises to a segment within digital healthcare technology and is emphasized for its accuracy, scalability, and capacity to improve patient outcomes by providing advanced, sustainable, and smart imaging solutions.

Impact of Recent Tariff Policies

In recent years, tariff regulations have become a more significant disruptive force in the BRIC diagnostic imaging equipment market, increasing the cost of imports, changing trade flows, and modifying competitive dynamics among manufacturers. A notable share of imaging components, including semiconductors, sensors, and digital imaging modules, are imported from major technology hubs in Asia, Europe, and North America. Therefore, the impact of higher import duties on these essential components has increased overall production and procurement costs, which manufacturers are usually compelled to pass on to healthcare providers or end users.

In response to the impact of tariffs, leading global producers of imaging equipment are restructuring their supply chains to source components locally or from regional manufacturing hubs to reduce reliance on imported goods and increase efficiency and cost of goods sold. For domestic manufacturers, this represents an opportunity to grow demand by offering competitively priced equipment that is not subject to tariffs. However, for distributors, hospitals, and diagnostic centers, rising prices of equipment related to import tariffs have led to budget constraints, deferred equipment upgrades, and slower growth in the mid-tier healthcare technology sector.

Report Scope

Regional Analysis

The BRIC Diagnostic Imaging Equipment Market is segmented by key countries and includes detailed analysis across countries. Below is a brief overview of the market dynamics in each country:

BRIC Region: The market for diagnostic imaging equipment in BRIC countries is showing rapid growth driven by population health care spending, an increasing array of diseases, and modernizing technologies.  The growth of digital, AI, and portable imaging will help enhance efficiency in diagnoses. Further enhancements to the market are being driven by governmental directives promoting domestic manufacturing as well as increasing digitization of health care across Brazil, Russia, India, and China.

• Brazil: In Brazil, the diagnostic imaging equipment market is benefiting from public–private partnerships as well as facility modernization among hospitals within the national health system (SUS). Demand is increasing for MRI and CT systems for oncology and cardiology, and the expansion of private diagnostic networks allows the newest technologies to be adopted into assessments and provides better access in both urban and regional segments.

• Russia: Russia’s growth is being supported by state-funded health care reform to modernize diagnostic technologies. The growth of funding directed to AI in radiology is allowing hospitals to develop more digital imaging archive capabilities and increasing the ability to accurately diagnose. However, the continuing impact of economic sanctions and global supply chain challenges will continue to impact international vendors within the Russian marketplace.

• India: Among the BRIC nations, India has one of the fastest-growing diagnostic imaging markets, supported by healthcare expansion under programs such as Ayushman Bharat and the Production-Linked Incentive (PLI) program for medical devices. Growing numbers of patients with chronic diseases, heightened awareness of preventive diagnostics, and a growing domestic capability to produce MRI and CT scanners are contributing to strong market momentum across the country.

• China: China is the biggest diagnostic imaging equipment market among the BRIC countries due to a large investment in healthcare as part of the “Healthy China 2030” initiative. Market growth is being aided by the large expansion of hospital infrastructure, rapid adoption of AI technology within radiology, and the government support of domestic imaging manufacturers. China is taking the lead in developing new AI-enabled scanning technologies and energy-efficient imaging technologies for hospitals and clinics.

Key Developments

The BRIC Diagnostic Imaging Equipment Market has undergone a number of important developments over the last couple of years as participants in the industry look to expand their geographic footprint and enhance their product offering and profitability by leveraging synergies.

• In January 2025, Royal Philips launched AI enabled CT 5300 at the 23rd Asian Oceanian Congress of Radiology (AOCR) 2025. Philips also celebrated the installation of 1500+ Helium Free 1.5T wide Bore (70 cm) MRI systems globally.

• In June 2022, Trivitron Healthcare launched made-in-India CT-Scan and MRI in the financial year 2022-23. Both domestic and international markets will benefit, and it will be aimed at promoting the ability for better diagnosis in remote areas, given the smart features, cost, and portability.

• In March 2022, At the Indian Radiological and Imaging Association 2022, Carestream Health India Announced Two New Breakthrough Imaging Solutions, DRX Compass and the LUX 35C detector.

These activities have allowed the companies to further develop their product portfolios and sharpen their competitive edge to capitalize on the available growth opportunities in the BRIC Diagnostic Imaging Equipment Market.

Leading Players

The BRIC Diagnostic Imaging Equipment Market is moderately consolidated, dominated by large-scale players with infrastructure and government support. Some of the key players in the market include:

• United Imaging Healthcare Company Limited
• Siemens Healthineers
• GE Healthcare
• Neusoft Corporation
• Basler AG
• Carestream Health, Inc.
• Arterys
• Hologic Inc.
• AiCure
• CURA Healthcare
• iCAD Inc.
• Others

The BRIC market for diagnostic imaging devices is moderately concentrated, including several large global manufacturers, local manufacturing options, and companies that apply artificial intelligence (AI) to the process of diagnostics. Major contributors to the overall market consolidation are traditionally recognized companies (dominant market leaders) like United Imaging Healthcare, Siemens Healthineers, and GE Healthcare, which have advanced imaging portfolios and well-established distribution networks throughout BRIC. Companies such as Neusoft Corporation, Carestream Health, and Hologic Inc. provide localized products or solutions in more selective imaging applications.

The sector also has a growing number of companies focused on the application and implementation of AI-driven diagnostics, including Arterys, AiCure, and iCAD Inc., to transition diagnostics to digitized cloud-based solutions in conjunction with hospital workflow. There are also regionally contributing companies, such as CURA Healthcare and Basler AG, which contribute to strengthening local supply chains. The combining of all players together demonstrates a growing ecosystem towards imaging technology and increasing access in Brazil, Russia, India, and China.

The BRIC Diagnostic Imaging Equipment Market is segmented as follows:

By Modality

• X-Ray Systems
• Nuclear Imaging Systems
• MRI Systems
• Mammography Systems
• Ultrasound Imaging Systems
• CT Scanners

By End-User

• Hospitals
• Diagnostic Imaging Centers